国家神经系统疾病临床医学研究中心数据管理与共享系统

Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

1p/19q-driven prognostic molecular classification for high-grade oligodendroglial tumors.

第一作者:Haihui Jiang

通讯作者:Song Lin

基本信息

  • 负责人:Haihui Jiang
  • 数据来源: OTHERS
  • 论文编号:OTHERS20190283
  • 发表时间:2014-08-24

2014-08-24

已发表文章

发表杂志:J Neurooncol

发表类型: Clinical Study

影响因子(IF): 3.129

PMID: 25151507 Pubmed原文链接 全文下载

主要研究背景及目的

方法

The present study was designed to project a molecular classification scheme based on the status of chromosome 1p and 19q. Patients (n = 117) with histological diagnosis of primary high-grade oligodendroglial tumors (HGOs) enrolled in the study. Fluorescence in situ hybridization (FISH) for chromosomes 1p and 19q was performed.

结论

The classification scheme incorporating traditional pathology with molecular information can be served as a supplement of the current WHO classification system and contribute to the personalized treatment decision-making.

主要结果

Univariate analysis showed that higher tumor grade, 1p/19q maintenance and 1q/19p co polysomy were confirmed as risk factors in HGOs (P < 0.01). Accordingly, patients with HGOs were divided into four subtypes which conferred remarkably distinct prognosis based on the number of risk factors (0 risk factor: HGOs-1, 1 risk factor: HGOs-2, 2 risk factors: HGOs-3, 3 risk factors: HGOs-4). Cox regression model revealed that the tumor grade was no longer independently associated with survival, while the molecular classification scheme showed a marked prognostic significance (HR = 0.359, 95 % CI 0.261-0.494, P < 0.001 for progression-free survival (PFS); HR = 0.393, 95 % CI 0.283-0.546, P < 0.001 for overall survival (OS)).